Browse the complete list of publications for studies listed on CDAS.
Filter results of publications table below
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. | 25928649 | Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA | Am. J. Respir. Crit. Care Med. | 2015 | NLST |
| Performance of the cancer risk management model lung cancer screening module. | 25993046 | Flanagan WM, Evans WK, Fitzgerald NR, Goffin JR, Miller AB, Wolfson MC | Health Rep | 2015 | NLST |
| Factor Structure and Stability of Smoking-Related Health Beliefs in the National Lung Screening Trial. | 25964503 | Kaufman AR, Koblitz AR, Persoskie A, Ferrer RA, Klein WM, Dwyer LA, Park ER | Nicotine Tob. Res. | 2015 | NLST |
| Automated pulmonary nodule CT image characterization in lung cancer screening. | 26122930 | Reeves AP, Xie Y, Jirapatnakul A | Int J Comput Assist Radiol Surg | 2015 | NLST |
| Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. | 26076313 | Park ER, Gareen IF, Japuntich S, Lennes I, Hyland K, DeMello S, Sicks JD, Rigotti NA | JAMA Intern Med | 2015 | NLST |
| Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. | 26052977 | Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T | Am. J. Respir. Crit. Care Med. | 2015 | NLST |
| Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare. | 25943596 | Roth JA, Sullivan SD, Goulart BH, Ravelo A, Sanderson JC, Ramsey SD | J Oncol Pract | 2015 | NLST |
| Cost-effectiveness of Lung Cancer Screening in Canada. | 26226181 | Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK | JAMA Oncol | 2015 | NLST |
| Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. | 26199983 | Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D | Am. J. Respir. Crit. Care Med. | 2015 | NLST |
| Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. | 25837734 | Fitzgerald NR, Flanagan WM, Evans WK, Miller AB, Canadian Partnership against Cancer (CPAC) Cancer Risk Management (CRM) Lung Cancer Working | Scand J Work Environ Health | 2015 | NLST |
| Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. | 26372542 | Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ | Cancer | 2015 | NLST |
| Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. | 26356134 | Balekian AA, Fisher JM, Gould MK | Chest | 2015 | NLST |
| The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. | 26502000 | Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA | Am. J. Respir. Crit. Care Med. | 2015 | NLST |
| Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. | 26712960 | Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER | Oncologist | 2015 | NLST |
| Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. | 26602092 | Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V | Urol. Oncol. | 2015 | NLST, PLCO |
| Data Processing and Analytic Support in the PLCO Cancer Screening Trial. | 26238116 | Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC | Rev Recent Clin Trials | 2015 | PLCO |
| The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. | 26238115 | Gohagan JK, Prorok PC, Greenwald P, Kramer BS | Rev Recent Clin Trials | 2015 | NLST, PLCO |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. | 26238117 | Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C | Rev Recent Clin Trials | 2015 | PLCO |
| Comprehensive Quality Management (CQM) in the PLCO Trial. | 26238118 | Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC | Rev Recent Clin Trials | 2015 | PLCO |
| Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 26238119 | Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P | Rev Recent Clin Trials | 2015 | PLCO |